Compare Dropbox Inc (DBX) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dropbox Inc vs GSK plc — how do they compare? Dropbox Inc trades at $33.81 (market cap $7.41B), while GSK plc trades at $50.26 (market cap $102.60B). The key difference: GSK plc is far larger — about 13.8× Dropbox Inc's market cap, and GSK plc pays a 3.57% dividend while Dropbox Inc pays none. Which is the better fit depends on your goals.
| DBX | GSK | |
|---|---|---|
Market Cap | $7.41B | $102.60B |
Sector | Technology | Health |
52-Week High | $35.00 | $61.18 |
52-Week Low | $22.06 | $38.22 |
Enterprise Value | $10.27B | $123.04B |
Dividend Yield | — | 3.57% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dropbox (DBX) trades at $33.79, down 2.31% today, but maintains a bullish technical trend with consistent earnings beats in recent quarters. The company reported Q2 2026 EPS of $0.75, exceeding expectations, and raised its full-year outlook. Strong profitability margins and positive cash flow trends support fundamentals, though negative shareholder equity and high debt levels present financial risks. Analyst sentiment is mixed with a balanced buy/hold/sell distribution.
The outlook for DBX is cautiously optimistic, driven by earnings momentum and AI expansion, but investors face risks from leveraged balance sheets and competitive pressures. Upside potential hinges on sustained core business growth, while downside risks include debt servicing and market volatility. The stock offers growth appeal but requires monitoring of financial health.
GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.
The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dropbox Inc
Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.
Read more on DBX →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
